Peringkat dalam Saham
#32515
Pharmena S.A. engages in the sale of dietary supplements in Poland and... Pharmena S.A. engages in the sale of dietary supplements in Poland and internationally. It also develops 1-MNA (PHR-701 program), a medical device for use in difficult-to-heal wounds. In addition, the company is involved in research and development of therapeutic applications of 1 MNA as an anti-inflammatory and anti-fibrotic drug; and research and development at pulmonary fibrosis, respiratory tract infections, including viral infections, COVID-19, inflammatory diseases, metabolic diseases and other therapeutic applications. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. Pharmena S.A. operates as a subsidiary of Pelion S.A.
Kapitalisasi Pasar
$9.88M
Perubahan (1 hari)
-1.56%
Perubahan (1 tahun)
-7.31%
Perdagangan Pharmena S.a. (PHR)
Harga PHR dengan kapitalisasi pasar B
Kapitalisasi pasar dari Pharmena S.a.(PHR)
Kapitalisasi Pasar: $9.88M
Per August 2026, Pharmena S.a. memiliki kapitalisasi pasar sebesar $9.88M. Ini menjadikan Pharmena S.a. sebagai perusahaan 32515th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Pharmena S.a. dari 2008 hingga 2026
PHR dibandingkan dengan 5 teratas stocks paling populer
| Harga PHR |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.460T
|
+55,281,968.54%
|
|
|
|
|
$4.489T
|
+45,454,407.56%
|
|
|
|
|
$4.141T
|
+41,925,023.08%
|
|
|
|
|
$3.569T
|
+36,130,097.11%
|
|
|
|
|
$2.798T
|
+28,328,999.74%
|
